Literature DB >> 29808008

Convergence of placenta biology and genetic risk for schizophrenia.

Gianluca Ursini1,2,3, Giovanna Punzi1,2, Qiang Chen1, Stefano Marenco4,5, Joshua F Robinson6, Annamaria Porcelli2, Emily G Hamilton6, Marina Mitjans7, Giancarlo Maddalena2, Martin Begemann7, Jan Seidel7, Hidenaga Yanamori8, Andrew E Jaffe1,9, Karen F Berman4, Michael F Egan10, Richard E Straub1, Carlo Colantuoni11,12,13, Giuseppe Blasi2, Ryota Hashimoto8,14, Dan Rujescu15, Hannelore Ehrenreich7, Alessandro Bertolino2, Daniel R Weinberger16,17,18,19,20,21.   

Abstract

Defining the environmental context in which genes enhance disease susceptibility can provide insight into the pathogenesis of complex disorders. We report that the intra-uterine environment modulates the association of schizophrenia with genomic risk (in this study, genome-wide association study-derived polygenic risk scores (PRSs)). In independent samples from the United States, Italy, and Germany, the liability of schizophrenia explained by PRS is more than five times greater in the presence of early-life complications (ELCs) compared with their absence. Patients with ELC histories have significantly higher PRS than patients without ELC histories, which is confirmed in additional samples from Germany and Japan. The gene set composed of schizophrenia loci that interact with ELCs is highly expressed in placenta, is differentially expressed in placentae from complicated in comparison with normal pregnancies, and is differentially upregulated in placentae from male compared with female offspring. Pathway analyses reveal that genes driving the PRS-ELC interaction are involved in cellular stress response; genes that do not drive such interaction implicate orthogonal biological processes (for example, synaptic function). We conclude that a subset of the most significant genetic variants associated with schizophrenia converge on a developmental trajectory sensitive to events that affect the placental response to stress, which may offer insights into sex biases and primary prevention.

Entities:  

Mesh:

Year:  2018        PMID: 29808008     DOI: 10.1038/s41591-018-0021-y

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  73 in total

Review 1.  [A selective review of recent research results in biological psychiatry].

Authors:  A Meyer-Lindenberg
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

2.  Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.

Authors:  Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

3.  Risk taking and impulsive behaviour: fundamental discoveries, theoretical perspectives and clinical implications.

Authors:  Anthony R Isles; Catharine A Winstanley; Trevor Humby
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

4.  Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci.

Authors:  Aditya Ambati; Ryan Hillary; Smaranda Leu-Semenescu; Hanna M Ollila; Ling Lin; Emmanuel H During; Neal Farber; Thomas J Rico; Juliette Faraco; Eileen Leary; Andrea N Goldstein-Piekarski; Yu-Shu Huang; Fang Han; Yakov Sivan; Michel Lecendreux; Pauline Dodet; Makoto Honda; Natan Gadoth; Sona Nevsimalova; Fabio Pizza; Takashi Kanbayashi; Rosa Peraita-Adrados; Guy D Leschziner; Rosa Hasan; Francesca Canellas; Kazuhiko Kume; Makrina Daniilidou; Patrice Bourgin; David Rye; José L Vicario; Birgit Hogl; Seung Chul Hong; Guiseppe Plazzi; Geert Mayer; Anne Marie Landtblom; Yves Dauvilliers; Isabelle Arnulf; Emmanuel Jean-Marie Mignot
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

Review 5.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

Review 6.  The fetal origins of mental illness.

Authors:  Benjamin J S Al-Haddad; Elizabeth Oler; Blair Armistead; Nada A Elsayed; Daniel R Weinberger; Raphael Bernier; Irina Burd; Raj Kapur; Bo Jacobsson; Caihong Wang; Indira Mysorekar; Lakshmi Rajagopal; Kristina M Adams Waldorf
Journal:  Am J Obstet Gynecol       Date:  2019-06-15       Impact factor: 8.661

7.  Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In Utero.

Authors:  Benjamin J S Al-Haddad; Bo Jacobsson; Shilpi Chabra; Dominika Modzelewska; Erin M Olson; Raphael Bernier; Daniel A Enquobahrie; Henrik Hagberg; Svante Östling; Lakshmi Rajagopal; Kristina M Adams Waldorf; Verena Sengpiel
Journal:  JAMA Psychiatry       Date:  2019-06-01       Impact factor: 21.596

8.  Research Domain Criteria: Strengths, Weaknesses, and Potential Alternatives for Future Psychiatric Research.

Authors:  Christopher A Ross; Russell L Margolis
Journal:  Mol Neuropsychiatry       Date:  2019-08-13

9.  Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Authors:  Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 10.  Genomic updates in understanding PTSD.

Authors:  Sumeet Sharma; Kerry J Ressler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-11-16       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.